1472 results
Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.
Abstracts session 1
06 Dec 2023 – From GulfPCR-GIM 2023
Broaden your knowledge with this selection of abstracts submitted to GulfPCR-GIM 2023, covering topics such as aortic procedures, LV function recovery after CTO recanalization, and the state of PCI in the region of Kurdistan in Iraq.
TAVI for bicuspid aortic stenosis patients - Recorded cases
05 Dec 2023 – From GulfPCR-GIM 2023
Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.
- An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...
Valve-in-valve: not as simple as it looks
05 Dec 2023 – From GulfPCR-GIM 2023
Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.
From access to annulus: overcoming challenging anatomies
05 Dec 2023 – From GulfPCR-GIM 2023
Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...
How to manage paravalvular leaks?
04 Jan 2024 – From PCR London Valves 2023
Invited to talk about paravalvular leaks, Grzegorz Smolka, Patrick Calvert and Xavier Freixa begin by placing the subject in context, mentioning the frequency with which it is encountered in general practice.
Then, they distinguish between patients likely to benefit from paravalvular leak closure via transcatheter and those...
Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients
05 Dec 2023 – From PCR London Valves 2023
Two cardiac surgeons, Hendrik Treede and Michael Reardon, and an echo specialist, Joao Cavalcante, have been invited to share their views on aortic regurgitation management.
So far, surgery remains the gold standard, and they explain why, by also comparing repair and replacement, before discussing the challenge that...
What does lifetime management mean for the valve patient?
10 Jan 2024 – From PCR London Valves 2023
Bettina Kirk, Alexandra Baer and John Webb discuss the question of lifetime management for valve disease patients, and begin by outlining the main difficulties involved, offering both an interventional cardiologist's and a nurse's perspective.
Then, they are considering how this lifetime management could be improved in the...
How to anticipate, plan and perform a TAV-in-TAV?
25 Jan 2024 – From PCR London Valves 2023
By 2023, although TAVI has become a safe routine procedure, it is now its long-term durability and the planning of a second procedure, particularly in younger patients, that is causing concern.
Vinayak Bapat and Bernard Prendergast discuss how to anticipate any potential TAV-in-TAV, take into account any...
What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?
29 Nov 2023 – From PCR London Valves 2023
Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...
Navigating complexity: surgical valve degeneration and complex coronary artery disease in a multimorbid patient
14 Dec 2023
How would you treat this 83-year-old male patient with LM, MVD, RCA CTO, severely reduced EF, and constrictive surgical valve?
Author
Author
Author
Focus on aortic valves
22 Nov 2023 – From PCR London Valves 2023
Simon Redwood and Christopher Cook cover the top three highlights of the aortic track at #PCRLV 2023:
- LIVE and recorded cases showcasing procedures from simple to highly complex.
- Engaging discussions on TAV in TAV procedures to enhance our ability to effectively treat patients.
- Long-term data and late trial results...
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
Extend your scope of practice beyond traditional roles
21 Nov 2023 – From PCR London Valves 2023
Explore this session to expand your professional horizons within the cath lab, uncovering a spectrum of opportunities, and gain insights into the indispensable role that seasoned nurses and allied professionals assume in supporting the Heart Team throughout transcatheter valve interventions.
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
